The partners will develop next-generation sequencing-based tests for precision cancer treatment for the Asian market.
Researchers identified trait-related variants by sequencing more than 400 upland cotton accessions and nearly 250 representatives from two diploid Gossypium species.
The lab is located within Novogene's sequencing center at the Sacramento campus of the University of California, Davis.
The Chinese government has implemented clearer regulatory guidance for genomic tests and invested in both clinical testing and research, spurring growth.
The firms plan to focus on sample processing methods, workflow automation, algorithms, and database construction.
Novogene will validate Trovagene's proprietary urine collection and nucleic acid preservation device, NextCollect, and develop tests for the Chinese market.
The Genome Institute of Singapore will collaborate with the new center to develop applications related to cancer diagnosis and treatment stratification.
The genomic sequencing firm will use the financing to support growth in both the research and clinical NGS market.
NovogeneAIT Genomics Singapore plans to collaborate with research institutes, utilizing the Illumina HiSeq X Ten for whole-genome sequencing.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.